In Brief
Pathogenic Yersinia secrete effectors called Yops, which can trigger or inhibit protective immune responses. Chung et al. demonstrate that both YopE and YopT inactivate RhoA, resulting in activation of the pyrin inflammasome. Consequently, Yersinia maintain virulence by delivering YopM, which hijacks host kinases to phosphorylate pyrin and inhibit inflammasome activation.
INTRODUCTION
Caspase-1 is activated by cytosolic multiprotein complexes known as inflammasomes and plays an important protective role in response to infection (Schroder and Tschopp, 2010) . Following recognition of distinct pathogen-associated molecular patterns, inflammasomes are typically assembled through homotypic interactions among nucleotide-binding oligomerization domain leucine-rich repeat-containing receptors (NLRs), apoptosis-associated speck-like protein containing a CARD (ASC), and caspase-1. The NLRP3 inflammasome senses disruptions in cellular homeostasis by exogenous ATP or bacterial pore-forming toxins, whereas NLRC4 and AIM2 inflammasomes respond to cytosolic contamination with bacterial components such as flagellin and double-stranded DNA, respectively. Recently, certain bacterial toxins that inhibit RhoA GTPases have been shown to activate the pyrin inflammasome through an indirect mechanism (Xu et al., 2014) . RhoA activates the serine/threonine protein kinase C-related kinases (PRK or PKN) that bind to and phosphorylate pyrin (Park et al., 2016) . Phosphorylated pyrin binds to 14-3-3 proteins, which negatively regulate the pyrin inflammasome (Park et al., 2016) . Despite the specificity of different inflammasomes for their cognate signals or the requirement for ASC, assembly culminates in the activation of caspase-1, resulting in a form of cell death known as pyroptosis (Bergsbaken et al., 2009) as well as the maturation of IL-1b and IL-18 (Cerretti et al., 1992; Ghayur et al., 1997; Thornberry et al., 1992) . The combined activity of these caspase-1 effector functions directs antimicrobial responses to promote clearance of pathogens. Therefore, counteracting caspase-1 activation is an important virulence strategy employed by bacterial pathogens.
Pathogenic Yersinia species (Y. pestis, Y. pseudotuberculosis, and Y. enterocolitica) utilize a contact-dependent type III secretion system (T3SS) to deliver Yersinia outer proteins (Yops) into the eukaryotic host cell cytosol (Cornelis, 2006) . Yop effectors modulate a multitude of cellular processes upon cytosolic entry, including the disruption of phagocytosis and proinflammatory gene expression (Viboud and Bliska, 2005) . For example, YopE and YopT contribute to inhibition of phagocytosis by inactivating Rho GTPases (Viboud and Bliska, 2005) . Furthermore, inflammasome activation is also inhibited during Yersinia infection, specifically by the virulence effectors YopK and YopM. YopK has been shown to interact with components of the Yersinia translocation machinery, YopB and YopD, to restrict their aberrant translocation into infected host cells, thereby limiting activation of NLRP3 and NLRC4 inflammasomes (Brodsky et al., 2010; Zwack et al., 2015) . The leucine-rich repeat (LRR)-containing protein YopM, another effector important for Yersinia virulence (Leung et al., (Chung et al., 2014; LaRock and Cookson, 2012) . Recent studies showed that the virulence defect of a Yersinia yopM mutant was reversed in mice lacking caspase-1 (Chung et al., 2014; LaRock and Cookson, 2012) , indicating that YopM promotes virulence by inhibiting caspase-1. There is evidence that YopM can act as a pseudosubstrate for caspase-1 (LaRock and Cookson, 2012) , but this activity may not be essential for YopM to block inflammasome activation (Chung et al., 2014) . Structurally, YopM consists of an N-terminal secretion signal followed by two a helices that initiate folding into the LRR region and finally terminates in an unstructured C-terminal tail (Evdokimov et al., 2001) . Because YopM lacks catalytic function and interacts with multiple host target proteins, it is thought to act as a scaffold. The LRR region binds to PRKs, and the C-terminal tail binds to ribosomal S6 kinase (RSK) (McCoy et al., 2010; McPhee et al., 2010) , resulting in kinase activation and increased phosphorylation of a heterologous substrate (Hentschke et al., 2010; McDonald et al., 2003) . There have been no reported interactions between PRKs and RSKs under physiological conditions. Interestingly, the activities of several known targets of the individual kinases are not altered in the presence of YopM (Hentschke et al., 2010; McDonald et al., 2003) , suggesting that complex formation redirects their substrate specificity. However, to date, endogenous targets of YopM-associated kinases remain enigmatic.
The pyrin inflammasome is negatively regulated by PRKs through the RhoA signal transduction pathway (Park et al., 2016 ). Here we demonstrate that the pyrin inflammasome is a key regulator of the innate immune response during Yersinia infection and the specific target of YopM. Mice lacking functional pyrin are particularly susceptible to infection with a Yersinia yopM mutant, underscoring the importance of pyrin for host defense and demonstrating that YopM inhibits pyrin to promote virulence. These results uncover a mechanism by which a pathogen hijacks host kinases and evades effector-triggered activation of caspase-1.
RESULTS

YopM Inhibits the Pyrin Inflammasome to Counteract
Host Defense against Yersinia Bone marrow-derived macrophages (BMDMs) infected with wild-type (WT) Yersinia fail to mobilize caspase-1-dependent responses due to the activity of two effectors, YopK and YopM (Brodsky et al., 2010; Chung et al., 2014, LaRock and Cookson, 2012; Zwack et al., 2015) . Perplexingly, Yersinia yopK mutants translocate YopM into infected macrophages but fail to inhibit activation of caspase-1 (Brodsky et al., 2010; Chung et al., 2014; Zwack et al., 2015) . Likewise, yopM mutants, which are competent for YopK translocation upon infection, are also unable to inhibit activation of caspase-1 in macrophages (Chung et al., 2014; LaRock and Cookson, 2012) . These observations suggest that these effectors inhibit distinct pathways of caspase-1 activation during Yersinia infection. Previous studies have demonstrated that the NLRP3 and NLRC4 inflammasomes are important for activation of caspase-1 in macrophages infected with a Yersinia yopK mutant (Brodsky et al., 2010) , but the specific inflammasome that is activated by a yopM mutant has not been identified. Hence, we investigated which inflammasomes respond to Yersinia yopM mutant infection by utilizing BMDMs from C57BL/6 mice deficient in various inflammasome components.
Consistent with previous studies, WT Yersinia (32777) did not induce caspase-1 activation, IL-1b, or lactate dehydrogenase (LDH) release from LPS-primed WT BMDMs, while the yopM mutant (DyopM) failed to inhibit these processes ( Figures S1A-S1C 
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À/À mice ( Figures 1A-1F and S1A-S1C). There was slight but significant contribution of NLRP3 and NLRC4 for IL-1b secretion in response to the yopM mutant ( Figure 1B) . Asc À/À BMDMs infected with the yopK mutant (DyopK), which stimulates both NLRP3 and NLRC4 inflammasomes (Brodsky et al., 2010) , exhibited a defect in cleavage of caspase-1 and secretion of IL-1b ( Figures 1A and 1B ), while caspase-1 processing and IL-1b release were largely absent in Nlrp3
BMDMs infected with the yopK mutant ( Figures 1A and 1B) . Levels of LDH release remained unchanged in Nlrp3
and Asc À/À BMDMs infected with the yopK mutant ( Figure 1C ), which may reflect caspase-11-dependent cell death (Casson et al., 2013 (Chung et al., 2014; LaRock and Cookson, 2012 Figure S2A ) revealed that inhibition of caspase-1 processing, IL-1b secretion, LDH release, and ASC foci formation is a conserved function of multiple YopM variants ( Figures  S2B-S2J ). We conclude that most, if not all, YopM isoforms have the ability to restrict activation of caspase-1 by targeting the pyrin inflammasome.
A previous report presented evidence that the YopM YPIII isoform used a pseudosubstrate mechanism to directly inhibit caspase-1, which was mediated by a critical aspartic acid residue (amino acid 271) within a YLTD motif found in this effector (LaRock and Cookson, 2012 Figure S2K ). Importantly, none of the YopM variants were able to significantly inhibit IL-1b secretion induced by infection with the effectorless mutant ( Figure S2K ). However, IL-1b secretion was significantly reduced when YopK was expressed in a single yopK mutant or the effectorless mutant ( Figure S2K ). Collectively, our data demonstrate that YopM specifically restricts the pyrin inflammasome independent of a YLTD motif and, unlike YopK, is unable to inhibit NLRP3 and NLRC4 inflammasome activation by the effectorless mutant. The conserved ability of distinct YopM isoforms to inhibit pyrin inflammasome activation led us to investigate the role of pyrindependent responses for in vivo protection against Yersinia infection. WT (32777) or yopM mutant Yersinia were used to intravenously infect C57BL/6 Mefv +/+ or Mefv À/À mice, and time to death was monitored. Mefv +/+ mice were highly susceptible to infection with WT Yersinia, but not with the yopM mutant ( Figure 2A ). In contrast, Mefv À/À mice were susceptible to both WT Yersinia and the yopM mutant ( Figure 2B ). Furthermore, enumeration of bacterial burdens in the spleens and livers of Mefv +/+ mice at 5 days post-infection showed an approximate one-log decrease of the yopM mutant relative to WT Yersinia, and the decreased colonization was reversed in Mefv À/À mice ( Figures 2C and 2D ). Taken together, these findings indicate an essential role for the pyrin inflammasome in controlling bacterial burdens of yopM mutant Yersinia and suggest that YopM promotes in vivo virulence by suppressing the pyrin inflammasome.
The Catalytic Activities of YopE and YopT Trigger Pyrin Inflammasome Activation
The primary targets of the effectors YopE and YopT are Rho GTPases, including RhoA, which regulates pyrin inflammasome activation (Park et al., 2016) . Specifically, YopE mimics eukaryotic GTPase-activating proteins (GAPs) by facilitating GTP hydrolysis (Black and Bliska, 2000) , and YopT is a cysteine protease that cleaves the C terminus of Rho GTPase, which results in its release from membranes (Shao et al., 2002 (Shao et al., , 2003 . To examine whether pyrin inflammasome activation is triggered by YopE or YopT, we infected BMDMs with yopM mutant strains expressing catalytically dead YopE (YopE R144A ) and/or YopT (YopT C139A ). Yersinia yopM mutant-induced pyrin inflammasome activation was significantly reduced when both YopE and YopT were inactivated ( Figures 3A-3C ), which corresponded to RhoA activation ( Figure S3 ), while an intermediate phenotype was seen with each individual mutant ( Figures 3A-3C ). In addition, consistent with previous observations (Chung et al., 2014) , pyrin inflammasome activation required YopB because a Yersinia yopByopM mutant defective in effector translocation failed to activate caspase-1 (Figures 3A-3C and 3G). Furthermore, the yopM mutant induced ASC foci formation, which was dependent on YopB, and YopE and YopT catalytic activities ( Figures 3D-3I ). These findings indicate that BMDMs infected with Yersinia mobilize the pyrin inflammasome as an effector-triggered immune response following inactivation of RhoA by YopE or YopT. into proteins by phosphorylation was assessed by SDS-PAGE and autoradiography ( Figure 5B ). Parallel kinase reactions were performed using cold ATP and analyzed by western blot to verify the presence of PRK2, RSK1, and YopM, as well as pyrin ( Figure 5B) . A band corresponding to phosphorylated transfected pyrin was detected in the corresponding GSTYopM 32777 samples, but not in the GST control ( Figure 5B ).
Immunoprecipitation with an Myc antibody confirmed that the phosphorylated band was pyrin ( Figure 5B ). These results identify pyrin as a target of YopM-associated kinases and suggest that this complex might inhibit inflammasome activation during Yersinia infection.
To further evaluate the role of PRK and RSK activity in YopMmediated suppression of the pyrin inflammasome, BMDMs were left uninfected or infected with WT Yersinia or the yopM mutant in the presence or absence of the PRK inhibitor PKC412 (Falk et al., 2014) , RSK inhibitor BI-D1870 (Sapkota et al., 2007) , or a combination of the two, and caspase-1 processing was measured.
Uninfected BMDMs treated with inhibitors did not contain active caspase-1 ( Figure 5C ), indicating that kinase inhibition is not sufficient to activate the pyrin inflammasome. Inhibition of either PRK or RSK did not alter caspase-1 processing in BMDMs infected with the yopM mutant, but inhibition of PRK, and not RSK, partially restored cleavage of caspase-1 in BMDMs infected with the WT strain ( Figure 5C ). We observed reduced phosphorylation of the known RSK target GSK-3b upon treatment of uninfected BMDMs with BI-D1870 ( Figure S5 ), indicating that the inhibitor was effective at the concentration used. Importantly, the presence of kinase inhibitors did not negatively affect translocation of YopM ( Figure 5C ). To more precisely evaluate the contribution of PRK, secreted IL-1b was measured from Yersinia-infected BMDMs transiently transfected with scrambled control siRNAs or siRNAs targeting the most ubiquitously expressed and functionally redundant isoforms Prk1 and Prk2 (Palmer et al., 1995) . Consistent with previous data, we observed a YopM-dependent inhibition of IL-1b release in control-transfected BMDMs ( Figure 5D ). In contrast, YopM failed to inhibit IL-1b in PRK1/PRK2 knockdown BMDMs ( Figure 5D ). These results indicate that during Yersinia infection, YopM hijacks PRK activity to restrict the pyrin inflammasome.
YopM Enhances PRK-Mediated Pyrin Phosphorylation
Our findings reveal that while YopM/PRK/RSK complexes are competent for pyrin phosphorylation ( Figures 5A and 5B) , the activity of PRK appears to be specifically important for suppression of inflammasome activation ( Figures 5C and 5D) . To assess the contribution of YopM to PRK-dependent pyrin phosphorylation, we incubated recombinant PRK1 or PRK2 DyopM-infected BMDMs. ASC, red; Yersinia, green; nuceli, blue. Scale bar represents 10 mm.
(I) Quantification of BMDMs containing ASC foci from images in (D)-(H).
Data in (B), (C), and (I) represent average values ± SEM from three independent experiments compared to yopM mutant-infected BMDMs as analyzed by one-way ANOVA. *p < 0.05; ***p < 0.001; ****p < 0.0001. See also Figure S3. and GST or GST-YopM 32777 with a purified N-terminal fragment of pyrin containing the critical serine residues important for inflammasome regulation (Masters et al., 2016; Park et al., 2016) . Incubation of GST with PRK1 or PRK2 revealed an intrinsic ability of either kinase to phosphorylate pyrin, as measured by serine phosphorylation (Figure 6 ). Importantly, addition of GST-YopM 32777 enhanced the abundance of phosphorylated serine (Figure 6 ), indicating that YopM interaction with PRKs enhances pyrin phosphorylation. Thus, our data show that YopM-associated PRK has increased ability to phosphorylate pyrin in vitro, suggesting that this post-translational modification negatively regulates activation of the pyrin inflammasome.
DISCUSSION
Bacterial pathogens employ specialized secretion systems to deliver virulence effectors into the cytosol of host cells to disrupt a multitude of signaling pathways. While these features are essential for pathogenesis, they may inadvertently trigger host responses. For example, cytosolic disruptions triggered by the Yersinia T3SS sets in motion the formation of inflammasomes that activate proinflammatory caspase-1. Therefore, limiting innate immune recognition of the T3SS in the host cell is vital toward promoting virulence of Yersinia and other bacterial pathogens with this type of specialized secretion system.
Here we determine that the pyrin inflammasome specifically recognizes inactivation of Rho GTPases by YopE or YopT during Yersinia infection of macrophages. These results extend recent findings of how bacterial pathogens (Dumas et al., 2014; Gavrilin et al., 2012) , and more specifically bacterial toxins that modify the switch I region of RhoA (Aubert et al., 2016; Xu et al., 2014) , stimulate the pyrin inflammasome. For example, TcdB of Clostridium difficile, which glucosylates Thr37 in switch I of RhoA, activates the pyrin inflammasome (Xu et al., 2014) . In contrast, the Rho-inactivation domain (RID) of a Vibrio RTX toxin, which enhances GTP hydrolysis by RhoA, did not trigger activation of caspase-1, leading the authors to conclude that only inactivation of RhoA by covalent modification of switch I triggers the pyrin inflammasome (Xu et al., 2014) . Both YopE GAP and YopT protease activities stimulate the pyrin inflammasome, but neither of these toxins covalently modify switch I of RhoA. However, YopE, by promoting GTP hydrolysis, and YopT, by catalyzing cleavage and detachment from the plasma membrane, prevent RhoA from activating downstream partners (Aktories, 2011), such as PRK (Zong et al., 1999) , which negatively regulates pyrin by phosphorylation (Park et al., 2016) . When RhoA is in the GTPbound conformation, it interacts, primarily via switch I, with the N-terminal homology region (HR1) of PRK2, leading to kinase activation (Zong et al., 1999) . These data suggest that the pyrin inflammasome is activated in response to bacterial toxins that either directly (e.g., TcdB) or indirectly (e.g., YopE, YopT) prevent RhoA from interacting with and activating PRK at the plasma membrane. This conclusion is consistent with the known mechanism of Clostridium botulinum C3 toxin, which ADP ribosylates RhoA on Asn41 at the C-terminal border of switch I (Aktories, 2011). This modification does not directly prevent RhoA from interacting with downstream partners, but instead traps the GTPase in the cytosol in a complex with guanine-nucleotide dissociation inhibitor 1 (Aktories, 2011). Moreover, defects in geranylgeranylation lead to pyrin-dependent inflammatory diseases (Akula et al., 2016; Park et al., 2016) , consistent with our results that general disruption of the RhoA signaling pathway stimulates inflammasome activation. Further studies are necessary to resolve why GTP hydrolysis in RhoA catalyzed by Yersinia YopE, but not Vibrio RID, triggers the pyrin inflammasome.
YopE-and YopT-mediated activation of the pyrin inflammasome in Yersinia-infected macrophages is efficiently neutralized following delivery of YopM, thereby inhibiting ASC foci formation, caspase-1 processing, IL-1b secretion, and LDH release. A previous study presented evidence that YopM was unable to inhibit formation of ASC foci in Yersinia-infected macrophages (LaRock and Cookson, 2012) . However, these studies were performed using Yersinia yopK mutants, which trigger activation of NLRP3 and NLRC4 inflammasomes (Brodsky et al., 2010) (Venkatesan et al., 1991) and SspH1 of Salmonella (Miao et al., 1999) , it lacks the enzymatic domain found in these other bacterial virulence factors. Instead, YopM acts as a scaffold to bind various host proteins, including PRK2 and RSK1. Yersinia strains expressing deletion variants of YopM proteins unable to interact with PRK2 or RSK1 fail to inhibit activation of caspase-1 (Chung et al., 2014) DyopM, and time to death was monitored for 21 days. Results are plotted to day 15 and pooled from two independent experiments with four to six mice per group (n = 8-10). Survival curves were analyzed using the log-rank test. ****p < 0.0001. See also Figure S4 .
results provide an explanation for these previously published data by demonstrating that YopM usurps PRK activity to neutralize the pyrin inflammasome. We hypothesize that through binding and activation of PRK and RSK (McDonald et al., 2003) , YopM bypasses YopE-and YopT-inactivated RhoA to maintain pyrin in a negatively regulated state by phosphorylation and binding of 14-3-3 proteins (Park et al., 2016) . Reinforcing this hypothesis, we identify pyrin as an endogenous substrate to be phosphorylated by YopM-associated kinases, in particular PRK1 and PRK2 in vitro. Interestingly, we could not determine a role for RSK kinase activity in suppression of the pyrin inflammasome and propose instead that its interaction with YopM may be important for allosteric regulation in vivo. The relative contributions of particular PRK (PRK 1-3) and RSK (RSK 1-4) isoforms that can assemble with YopM (Hentschke et al., 2010) , as well as the precise molecular interactions required for association of pyrin with the complex, remain to be determined. The diversity of the LRR region of YopM also raises additional questions. To date, all YopM isoforms have been shown to inhibit the pyrin inflammasome, yet each isoform potentially interacts with a distinct range of host proteins. The purpose of this heterogeneity is still under investigation, but may enable specific isoforms to more efficiently restrict the pyrin inflammasome. Although inhibition of the pyrin inflammasome appears to be a major virulence function, there exist additional mechanisms by which YopM promotes pathogenesis (Hö fling et al., 2015) . For example, YopM has been shown to autonomously translocate into both the cytosol and nucleus of eukaryotic cells and can also suppress transcription of the proinflammatory cytokine TNFa (Rü ter et al., 2010; Scharnert et al., 2013; Hö fling et al., 2014) . Moreover, YopM is required for the induction of systemic levels of the anti-inflammatory cytokine IL-10 (McPhee et al., 2010 , possibly through interaction with nuclear helicases and RSKs (Berneking et al., 2016) . Lastly, YopM plays a key role in promoting neutrophil survival via processes independent of RSK and caspase-1 catalytic activities (Stasulli et al., 2015) . Taken together, these findings indicate that YopM could have multiple functions depending on the infected cell type, host protein interaction, or subcellular localization. For instance, the cytosolic fraction of YopM may inhibit inflammasome activation, while the nuclear fraction may modify gene expression. How these features contribute to Yersinia virulence remain important questions, but nevertheless suggest that the overall role of YopM may be to restrict inflammation.
Interestingly, individuals with gain-of-function mutations of pyrin (Touitou et al., 2004 ) present with episodes of periodic inflammation in a disease known as Familial Mediterranean fever (FMF). Another more recently identified pyrin mutation leads to a disease that is clinically distinct from FMF, and therefore termed pyrin-associated autoinflammation with neutrophilic dermatosis (PAAND) (Masters et al., 2016) . The prevalence of PAAND mutations remains to be determined, but the high carrier frequency of FMF in Mediterranean and Middle Eastern populations is suggested to be a result of a selective advantage in resistance to an unknown infection. It is intriguing to speculate that FMF or PAAND pyrin variants emerged to confer protection against Yersinia or other pathogens that actively evade the pyrin inflammasome. Use of knockin mice encoding pyrin FMF variants (Chae et al., 2011) or monocytes from PAAND patients (Masters et al., 2016) in infection assays may provide insight into the origin of these gain-of-function mutations, and will surely provide insights into human disease as well as the evolution of host-pathogen interactions.
EXPERIMENTAL PROCEDURES
Bacterial Strains Y. pseudotuberculosis strains used in this study are listed in Table S1 . Details on strain construction are also listed in the Supplemental Experimental Procedures. (Chae et al., 2003) mice, as previously described (Brodsky et al., 2010) . At 18 hr prior to infection, BMDMs were seeded in DMEM supplemented with 10% FBS, 10% L-cell-conditioned medium, 1 mM sodium pyruvate, 10 mM HEPES, and 100 ng/mL Escherichia coli LPS (Sigma) in 6-well plates at a density of 0.8 3 10 6 cells/well, except for fluorescence microscopy experiments, where they were seeded in 24-well plates at a density of 1.5 3 10 5 cells/well.
Bone Marrow Isolation and Culture Conditions
Macrophage Infections
For BMDM infections, Y. pseudotuberculosis strains were grown overnight in Luria broth (LB) at 28 C. The following day, cultures were diluted 1:40 in LB containing 20 mM sodium oxalate and 20 mM MgCl 2 and grown at 28 C for 1 hr, then shifted to 37 C for 2 hr. For analysis of Yop secretion, cultures were grown at 28 C for 2 hr, then shifted to 37 C for 4 hr. LPS-primed BMDMs were left uninfected or infected with Y. pseudotuberculosis strains cultured under conditions as described above at an MOI of 30. Tissue culture plates were centrifuged at 95 3 g for 5 min to promote contact of Yersinia with BMDMs and incubated at 37 C with 5% CO 2 . At 90 min post-infection, supernatants were collected and processed for secreted IL-1b and LDH release, while cell lysates were harvested for western blot analysis of host proteins. For infection experiments with kinase inhibitors BI-D1870 (10 mM) or PKC412 (5 mM) (Enzo Life Sciences), reagents were added simultaneously with bacteria to BMDMs at the start of infection. Transfection of BMDMs with scrambled control siRNAs or siRNAs targeting Prk1 and Prk2 were performed as previously described (Park et al., 2016) .
Cytokine Production
Levels of secreted IL-1b in supernatants collected from BMDMs were quantified using a commercially available ELISA kit (R&D Biosystems).
Cell Death Assays
Levels of LDH release in supernatants collected from BMDMs were analyzed using a commercially available cytotoxicity kit (Promega).
Western Blotting of Macrophage Lysate
BMDMs were lysed in 1% NP-40, 150 mM NaCl, and 50 mM Tris-HCl (pH 8.0) with protease inhibitor cocktail (Roche) and resolved by SDS-PAGE using Recombinant Myc-tagged N-terminal pyrin (amino acids 1-330) was incubated with either purified PRK1 or PRK2 and recombinant GST or GSTYopM 32777 , after which phosphorylation of pyrin was assessed by WB analysis for phosphorylated serine.
4%-12% or 12% NuPAGE Bis-Tris gels (Invitrogen). Proteins were transferred onto PVDF membranes and probed with rabbit polyclonal antibodies against caspase-1 (a gift from Gabriel Nuñ ez), YopM (a gift from Sue Straley), pyrin (Chae et al., 2003) , or phospho-GSK-3b (Cell Signaling); a rabbit monoclonal antibody against GSK-3b (Cell Signaling); and mouse monoclonal anti-YopE 202.19 and 149.27 antibodies (unpublished data). Anti-rabbit and anti-mouse antibodies (Jackson ImmunoResearch) conjugated to HRP were used as secondary reagents. An HRP-conjugated b-actin antibody (Sigma) was used to control for loading. Proteins were visualized using chemiluminescent detection reagent (GE Healthcare).
Analysis of Active RhoA Levels of GTP-bound RhoA were assessed by incubating BMDM lysates and Rhotekin-RBD beads (Cytoskeleton), as previously described (Park et al., 2016) .
Mouse Infections
Y. pseudotuberculosis cultures were grown overnight in LB at 28 C and prepared as PBS suspensions containing approximately 2.0 3 10 4 or 5.0 3 10 4 CFU/mL. A volume of 100 mL was delivered by tail vein injection into C57BL/6 or Mefv À/À mice. Time to death was monitored for 21 days, upon which the remaining mice were euthanized. At 5 days post-infection, spleens and livers were collected, homogenized, serially diluted, and plated onto LB agar to enumerate bacterial colonization. All mice were handled in accordance with guidelines for the humane care and use of experimental animals, and the procedures used were approved by the Stony Brook University Institutional Animal Care and Use Committee.
Analysis of Yop Secretion
Following growth of Y. pseudotuberculosis strains as described above, supernatants were clarified by centrifugation and precipitated with trichloroacetic acid. Samples were subsequently processed by western blot using a mouse monoclonal anti-YopM antibody CE 6-1 (a gift from Sue Straley).
Fluorescence Microscopy
BMDMs seeded onto glass coverslips were left uninfected or infected as described above, except that tissue culture medium was supplemented with 0.5 mM IPTG to induce GFP expression in Y. pseudotuberculosis strains harboring p67GFP3.1. BMDMs were washed, fixed, permeabilized, and blocked, as previously described (Pujol and Bliska, 2003) , and incubated with rabbit anti-Yersinia (Black and Bliska, 2000) or rat monoclonal anti-ASC (a gift from Gabriel Nuñ ez) antibodies. Binding of primary antibodies was visualized using FITC-conjugated anti-rabbit antibody (Sigma Immunochemicals) or Alexa Fluor 594-conjugated anti-rat antibody (Invitrogen), and DNA was stained with DAPI. Coverslips were mounted onto glass slides and imaged with an Axiovert S100 microscope (Zeiss). Three random fields of approximately 50 cells each were taken with a SPOT camera (Diagnostic Instruments) and processed with Adobe Photoshop.
Protein Purification E. coli strains harboring pGEX-2T vectors encoding YopM sequences from Y. pseudotuberculosis 32777, Y. pestis KIM, and Pestoides A, or Y. enterocolitica 8081 were expressed and purified, as previously described (Chung et al., 2014) .
GST Pulldowns
To construct a vector for expression of murine pyrin in mammalian cells, mRNA extracted from LPS-primed BMDMs was converted to cDNA using commercially available RNA isolation (QIAGEN) and reverse transcriptase (Invitrogen) kits. A DNA sequence encoding murine pyrin isoform 1 (GenBank: NM_001161790.1) with an N-terminal c-Myc epitope was amplified using PCR and the cDNA template, and inserted into the pMIGR1 vector. HEK293T cells were transfected with the pMIGR1 vector encoding pyrin or empty vector using the Lipofectamine 3000 transfection reagent (Invitrogen).
The following day, 10 mg GST-YopM 32777 or equimolar amounts of GST were added to 20 mL GST-Bind Resin (Novagen) and incubated for 30 min at 4 C. Beads were washed three times with GST Bind/Wash Buffer (Novagen) and incubated with lysates derived from transfected HEK293T cells in lysis buffer containing 0.1% NP-40, 150 mM NaCl, and 50 mM Tris-HCl (pH 8.0) for 2 hr at 4 C on a rotating shaker. Bound proteins were washed three times in lysis buffer, boiled in sample buffer, separated by SDS-PAGE, and western blotted using mouse monoclonal c-Myc (Cell Signaling) or YopM (a gift from Sue Straley) antibodies or rabbit polyclonal anti-RSK1 or anti-PRK2 antibodies (Abcam).
Kinase Assays
Pulldowns with GST or GST-YopM 8081 were performed as described above, except beads were incubated with lysates generated from nontransfected HEK293T cells. Bound proteins were washed three times in lysis buffer, followed by two washes in 20 mM HEPES (pH 7.4) and 10 mM MgAc. Kinase assays were performed at room temperature, as previously described (McDonald et al., 2003) . Parallel kinase reactions using cold ATP were performed, resolved by SDS-PAGE, and analyzed by western blot. In vitro kinase assays using N-terminal pyrin constructs were performed as previously described (Park et al., 2016) .
Statistical Analysis
Experimental data analyzed for significance were from at least three independent experiments using GraphPad Prism. p values for IL-1b, LDH, and fluorescence microscopy experiments were calculated using one-way ANOVA or grouped two-way ANOVA with Tukey's post-test. p values from mouse survival experiments and organ burdens were calculated by log-rank or Mann-Whitney tests, respectively. p < 0.05 was considered significant. 
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